|
⚲
|
| Keyboard |
| Henos Michael A
✚
|
|
|---|---|
| CIK # | 0001222543 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001222543] | |
| 4 | [0001222543] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Henos Michael A | |
| Crescent Biopharma Inc | |
| Inhibitex Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Crescent Biopharma Inc GLYC
Stock Option (right to buy) · derivative
|
2015-07-15 | Grant | 11,000 | $0.00 | |
|
Crescent Biopharma Inc GLYC
Common Stock
|
2014-12-22 | Sell | 10,659 | $8.44 | 89,962 |
|
Crescent Biopharma Inc GLYC
Common Stock
|
2014-12-19 | Sell | 10,598 | $8.61 | 91,249 |
|
Crescent Biopharma Inc GLYC
Common Stock
|
2014-12-17 | Sell | 5,121 | $8.97 | 45,935 |
|
Crescent Biopharma Inc GLYC
Common Stock
|
2014-12-15 | Option exercise | 43,628 | $0.33 | 14,397 |
|
Crescent Biopharma Inc GLYC
Warrant to Purchase Common Stock (right to buy) · derivative
|
2014-12-15 | Option exercise | 38,493 | $0.00 | |
|
Crescent Biopharma Inc GLYC
Warrant to Purchase Common Stock (right to buy) · derivative
|
2014-12-15 | Option exercise | 5,133 | $0.00 | |
|
Crescent Biopharma Inc GLYC
Common Stock
|
2014-12-15 | Sell | 1,604 | $8.98 | 14,404 |
|
Crescent Biopharma Inc GLYC
Common Stock
|
2014-06-13 | Buy | 5,000 | $6.21 | 31,050 |
|
Crescent Biopharma Inc GLYC
Common Stock
|
2014-06-12 | Buy | 6,000 | $6.54 | 39,240 |
|
Crescent Biopharma Inc GLYC
Stock Option (right to buy) · derivative
|
2014-04-03 | Option exercise | 1,562 | $0.00 | |
|
Crescent Biopharma Inc GLYC
Common Stock
|
2014-04-03 | Option exercise | 1,562 | $1.12 | 1,749 |
|
Crescent Biopharma Inc GLYC
Series A-1 Preferred Stock · derivative
|
2014-01-15 | Conversion | 39,413 | $0.00 | |
|
Crescent Biopharma Inc GLYC
Common Stock
|
2014-01-15 | Conversion | 337,579 | ||
|
Crescent Biopharma Inc GLYC
Common Stock
|
2014-01-15 | Conversion | 11,936 | ||
|
Crescent Biopharma Inc GLYC
Series A-1 Preferred Stock · derivative
|
2014-01-15 | Conversion | 1,114,690 | $0.00 | |
|
Crescent Biopharma Inc GLYC
Stock Option (right to buy) · derivative
|
2014-01-09 | Grant | 15,401 | $0.00 | |
|
Inhibitex Inc INHX
Stock Option (Right to Buy) · derivative
|
2012-02-13 | Disposed to issuer | 40,000 | $0.00 | |
|
Inhibitex Inc INHX
Stock Option (Right to Buy) · derivative
|
2012-02-13 | Disposed to issuer | 40,000 | $0.00 | |
|
Inhibitex Inc INHX
Stock Option (Right to Buy) · derivative
|
2012-02-13 | Disposed to issuer | 18,000 | $0.00 | |
| showing 20 of 25 most recent transactions | |||||